Psoriatic Arthritis : At a Glance

Speciality: Rheumatology


Speaker:

Dr. Vikram Lahoria | Consultant Dermatologist

Description:

A warm welcome to all the medical professionals in this interesting session on Psoriatic Arthritis : At a Glance
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects both the skin and joints, typically developing in individuals with psoriasis. Characterized by joint pain, stiffness, and swelling, PsA can lead to significant disability if not properly managed. It presents in various forms, including symmetrical arthritis, asymmetrical oligoarthritis, and spondylitis, each with distinct clinical features. Early diagnosis is crucial to prevent joint damage and maintain quality of life, as PsA can be progressive and debilitating.
Management of Psoriatic Arthritis involves a combination of treatments aimed at controlling inflammation, reducing pain, and improving joint function. Nonsteroidal anti-inflammatory drugs (NSAIDs) are often used for mild cases, while disease-modifying antirheumatic drugs (DMARDs) and biologics, such as TNF inhibitors and IL-17 inhibitors, are crucial for more severe cases. Biologics have revolutionized PsA treatment by targeting specific immune pathways involved in the disease process, offering significant improvements in both skin and joint symptoms. Regular monitoring and a multidisciplinary approach are essential to address the diverse manifestations of PsA and to adjust treatment as needed for optimal patient outcomes.
 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer during young adulthood carries long-term mental toll, study finds

2.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

3.

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot